A critical look at the surfactant therapy: when, how much, and what to use?
Pappert
D
D
Klinik für Anaesthesiologie und operative Intensivmedizin, WE01 Virchow-Klinikum, Humboldt Universität zu Berlin. dpappert@ukrv.de
Rossaint
R
R
D000280:Administration, Inhalation; D004334:Drug Administration Schedule; D006801:Humans; D011650:Pulmonary Alveoli / Q000503:physiopathology; D011659:Pulmonary Gas Exchange / Q000187:drug effects / Q000502:physiology; D011663:Pulmonary Surfactants / Q000008:administration & dosage / Q000737:chemistry / Q000502:physiology / Q000627:therapeutic use*; D012121:Respiration, Artificial; D012128:Respiratory Distress Syndrome / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy; D019141:Respiratory System Agents / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use*; D014692:Ventilation-Perfusion Ratio / Q000187:drug effects / Q000502:physiology
D011663:Pulmonary Surfactants; D019141:Respiratory System Agents